Search research articles
Contact Us
Filters
Showing results (121-130 of 136) with videos related to
Page
of 14
Sort By:
Physical Review Letters
|
August 6, 1990
Measurement of the absolute inclusive leptonic-decay branching fraction of the Ds+ meson
Bai, Blaylock, Bolton, et al.
Nature Communications
|
October 14, 2025
Analysis of cfDNA fragmentomics metrics and commercial targeted sequencing panels
Kyle T Helzer, Marina N Sharifi, Jamie M Sperger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 5, 2022
A Phase I Study Investigating AZD8186, a Potent and Selective Inhibitor of PI3Kβ/δ, in Patients with Advanced Solid Tumors
Atish D Choudhury, Celestia S Higano, Johann S de Bono, et al.
JAMA Cardiology
|
May 27, 2021
Prevalence of Clinical and Subclinical Myocarditis in Competitive Athletes With Recent SARS-CoV-2 Infection: Results From the Big Ten COVID-19 Cardiac Registry
Curt J Daniels, Saurabh Rajpal, Joel T Greenshields, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 7, 2017
A Phase II Trial of Neoadjuvant MK-2206, an AKT Inhibitor, with Anastrozole in Clinical Stage II or III <i>PIK3CA</i>-Mutant ER-Positive and HER2-Negative Breast Cancer
Cynthia X Ma, Vera Suman, Matthew P Goetz, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
April 8, 2020
NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 1.2020
Mary B Daly, Robert Pilarski, Matthew B Yurgelun, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
January 6, 2021
Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology
Mary B Daly, Tuya Pal, Michael P Berry, et al.
Contemporary Clinical Trials
|
May 4, 2024
Making Informed Choices On Incorporating Chemoprevention into carE (MiCHOICE, SWOG 1904): Design and methods of a cluster randomized controlled trial
K D Crew, G L Anderson, K B Arnold, et al.
BMC Medical Informatics and Decision Making
|
September 28, 2024
Use of web-based decision support to improve informed choice for chemoprevention: a qualitative analysis of pre-implementation interviews (SWOG S1904)
Alissa M Michel, Haeseung Yi, Jacquelyn Amenta, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 17, 2023
Fragmentomic analysis of circulating tumor DNA-targeted cancer panels
K T Helzer, M N Sharifi, J M Sperger, et al.
Page
of 14
Search research articles
Search
Showing results (121-130 of 136) with videos related to
Sort By:
Page
of 14
Physical Review Letters
|
August 6, 1990
Measurement of the absolute inclusive leptonic-decay branching fraction of the Ds+ meson
Bai, Blaylock, Bolton, et al.
Nature Communications
|
October 14, 2025
Analysis of cfDNA fragmentomics metrics and commercial targeted sequencing panels
Kyle T Helzer, Marina N Sharifi, Jamie M Sperger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 5, 2022
A Phase I Study Investigating AZD8186, a Potent and Selective Inhibitor of PI3Kβ/δ, in Patients with Advanced Solid Tumors
Atish D Choudhury, Celestia S Higano, Johann S de Bono, et al.
JAMA Cardiology
|
May 27, 2021
Prevalence of Clinical and Subclinical Myocarditis in Competitive Athletes With Recent SARS-CoV-2 Infection: Results From the Big Ten COVID-19 Cardiac Registry
Curt J Daniels, Saurabh Rajpal, Joel T Greenshields, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 7, 2017
A Phase II Trial of Neoadjuvant MK-2206, an AKT Inhibitor, with Anastrozole in Clinical Stage II or III <i>PIK3CA</i>-Mutant ER-Positive and HER2-Negative Breast Cancer
Cynthia X Ma, Vera Suman, Matthew P Goetz, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
April 8, 2020
NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 1.2020
Mary B Daly, Robert Pilarski, Matthew B Yurgelun, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
January 6, 2021
Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology
Mary B Daly, Tuya Pal, Michael P Berry, et al.
Contemporary Clinical Trials
|
May 4, 2024
Making Informed Choices On Incorporating Chemoprevention into carE (MiCHOICE, SWOG 1904): Design and methods of a cluster randomized controlled trial
K D Crew, G L Anderson, K B Arnold, et al.
BMC Medical Informatics and Decision Making
|
September 28, 2024
Use of web-based decision support to improve informed choice for chemoprevention: a qualitative analysis of pre-implementation interviews (SWOG S1904)
Alissa M Michel, Haeseung Yi, Jacquelyn Amenta, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 17, 2023
Fragmentomic analysis of circulating tumor DNA-targeted cancer panels
K T Helzer, M N Sharifi, J M Sperger, et al.
Page
of 14